Source: Wired
Summary
Faraday, an AI agent developed by British AI lab Inherent, can replicate scientific papers, according to a report. The lab was founded by former DeepMind employees. Inherent claims the tool could accelerate scientific innovation. The AI’s capabilities were demonstrated in a series of experiments. The project is part of a growing trend in AI-driven research tools.
Our Reading
The launch follows a familiar script.
Faraday can replicate scientific papers, a feature that sounds new but isn’t.
Inherent is made up of ex-DeepMind folks, which is always a selling point.
The AI is supposed to be a “stepping stone for innovation,” which is code for “we’re trying something different.”
Another AI that’s just a rebrand of old ideas, but with more hype.
Author: Evan Null
Rebranding the Same Old Thing
Faraday is the latest in a long line of AI tools that promise to revolutionize science. The problem is, it’s not really new. Replicating scientific papers is a task that’s been explored for years, but now it’s wrapped in a shiny new AI package.
Inherent, the company behind Faraday, has a strong pedigree. Its founders worked at DeepMind, a company that’s known for big promises and slow delivery. This is the same playbook, just with a different name.
The idea that AI can replicate scientific work is not groundbreaking. It’s more like a digital version of a research assistant, but with more buzzwords and fewer actual results.
Faraday’s ability to “replicate” papers is vague. Does it mean it can generate similar content? Or does it mean it can reproduce the exact same findings? The article doesn’t say, which is typical for these kinds of announcements.
What’s clear is that the tech world is still chasing the same old ideas, just with a different label. AI is the new magic pill, and every new startup is trying to sell it as the next big thing.
Another AI, Another Hype Cycle
Faraday is the latest in a long line of AI tools that claim to be revolutionary. But the truth is, it’s just another version of what’s been done before. The difference is the marketing.
Companies like Inherent are leveraging the AI hype to get attention. They’re not necessarily creating something new, but they’re making it sound like they are. That’s the real innovation here.
The article mentions that Faraday could be a “stepping stone for innovation,” but it doesn’t explain how. That’s the same way every AI startup talks—big on promise, light on detail.
It’s also worth noting that Inherent’s team has a history with DeepMind, a company that’s been accused of overpromising and underdelivering. This is the same pattern, just with a different group of people.
Faraday’s release is more about branding than actual progress. It’s the same story we’ve seen before, just with a different name and a different set of buzzwords.
The AI Hype Machine
AI is everywhere now, and it’s being used to sell everything from productivity tools to scientific research. The problem is, most of it is just rebranded versions of old ideas.
Faraday is a perfect example. It’s not that it’s not useful, but it’s not exactly groundbreaking either. The AI can replicate scientific papers, which is a task that’s been done before, just not with as much fanfare.
What’s interesting is how quickly these ideas get rebranded. A few years ago, this would have been called a research assistant. Now, it’s an AI agent, and suddenly it’s a big deal.
Companies like Inherent are taking advantage of the AI hype to get attention. They’re not necessarily creating something new, but they’re making it sound like they are. That’s the real innovation here.
Faraday is just another example of how the tech world keeps recycling the same ideas, just with a different label. It’s not progress—it’s just a rebrand.
Same Idea, New Name
Faraday is the latest in a long line of AI tools that promise to change the world. But the truth is, it’s just another version of what’s been done before. The difference is the marketing.
Companies like Inherent are leveraging the AI hype to get attention. They’re not necessarily creating something new, but they’re making it sound like they are. That’s the real innovation here.
The article mentions that Faraday could be a “stepping stone for innovation,” but it doesn’t explain how. That’s the same way every AI startup talks—big on promise, light on detail.
It’s also worth noting that Inherent’s team has a history with DeepMind, a company that’s been accused of overpromising and underdelivering. This is the same pattern, just with a different group of people.
Faraday’s release is more about branding than actual progress. It’s the same story we’ve seen before, just with a different name and a different set of buzzwords.
AI Is Just a New Label for Old Ideas
Faraday is the latest in a long line of AI tools that promise to revolutionize science. But the truth is, it’s not really new. Replicating scientific papers is a task that’s been explored for years, but now it’s wrapped in a shiny new AI package.
Inherent, the company behind Faraday, has a strong pedigree. Its founders worked at DeepMind, a company that’s known for big promises and slow delivery. This is the same playbook, just with a different name.
The idea that AI can replicate scientific work is not groundbreaking. It’s more like a digital version of a research assistant, but with more buzzwords and fewer actual results.
Faraday’s ability to “replicate” papers is vague. Does it mean it can generate similar content? Or does it mean it can reproduce the exact same findings? The article doesn’t say, which is typical for these kinds of announcements.
What’s clear is that the tech world is still chasing the same old ideas, just with a different label. AI is the new magic pill, and every new startup is trying to sell it as the next big thing.
